Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Endo International

Endo International reported $1.93B in Current Assets for its fiscal quarter ending in March of 2023.

Current Assets Change
Amarin AMRN:US USD 683.82M 5.28M
ANI Pharmaceuticals ANIP:US USD 364.75M 20.49M
Coherus Biosciences CHRS:US USD 402.43M 21.19M
Eli Lilly LLY:US USD 20.81B 2.78B
Endo International ENDP:US USD 1.93B 145.01M
Heron Therapeutics HRTX:US USD 178.16M 27.28M
Hikma Pharmaceutical HIK:LN USD 2B 145M
Horizon Pharma HZNP:US USD 3.6B 50M
Ligand Pharmaceuticals LGND:US USD 328.2M 64.59M
Novartis NOVN:VX USD 32.11B 4.8B
Pacira PCRX:US USD 376.11M 122.22M
Patterson Companies PDCO:US USD 1.84B 19.18M
Perrigo PRGO:US USD 2.74B 20.8M
Phibro Animal Health PAHC:US USD 585.48M 3.79M
Revance Therapeutics RVNC:US USD 323.02M 51.7M
Supernus Pharmaceuticals SUPN:US USD 883.34M 149.19M
Takeda 4502:JP JPY 2.4T 197.99B
Teva Pharmaceutical Industries Ltd TEVA:IT USD 11.5B 550M
Xeris Pharmaceuticals Inc XERS:US USD 165.51M 21.3M
Zoetis ZTS:US USD 6.27B 1.24B